CNX vs VRTX · P/E 4.5, rev $1.41B vs P/E 30, rev $3.33B
CNX Resources Corp (CNX) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
CNX Resources Corp (CNX) is a oil & gas e&p company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported CNX revenue for 2026-06-30 was $1.41B. Net income was $551.1M. Revenue was up 78.6% from 2026-03-31 to 2026-06-30. CNX currently screens at market cap $4.75B and trailing P/E 4.5.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
CNX currently screens at market cap $4.75B and trailing P/E 4.5. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the CNX and VRTX stock pages for the full models.
Not investment advice.